Stock Price
154.98
Daily Change
-2.18 -1.39%
Monthly
-11.54%
Yearly
90.29%
Q1 Forecast
152.04

Insmed reported $2.36B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
BioMarin Pharmaceutical USD 7.61B 158.53M Sep/2025
Cytokinetics USD 1.44B 210.92M Sep/2025
DBV Technologies USD 110.49M 32.93M Sep/2025
Dynavax Technologies USD 946.51M 28.06M Sep/2025
Gilead Sciences USD 58.53B 2.81B Sep/2025
Insmed USD 2.36B 119.12M Sep/2025
Novartis USD 107.29B 2.89B Sep/2025
Regeneron Pharmaceuticals USD 40.56B 389.3M Dec/2025
Sarepta Therapeutics USD 3.49B 186.38M Sep/2025
Ultragenyx Pharmaceutical USD 1.19B 115.82M Sep/2025
Vertex Pharmaceuticals USD 24.86B 825.6M Sep/2025